POTTERS BAR, ENGLAND, AND
PITTSBURGH, May 7, 2015 /PRNewswire/ -- Mylan N.V.
(Nasdaq: MYL), a leading global pharmaceutical company, today
announced the launch of EpiPen® On Location™.
This campaign is a national call-to-action to help those living
with potentially life-threatening (severe) allergies and their
caregivers understand the importance of being prepared for a
life-threatening allergic reaction (anaphylaxis) by avoiding
allergic triggers and having access to two epinephrine
auto-injectors, such as EpiPen® (epinephrine injection)
Auto-Injectors, at all times — whether at home, school, work or on
vacation. Studies reveal that nearly half of all anaphylactic
episodes happen outside of the home, increasing the importance of
having epinephrine in multiple locations. Epinephrine is the only
first-line treatment for anaphylaxis.
To view the multimedia assets associated with this release,
please
click: http://www.multivu.com/players/English/7160153-mylan-specialty-epipen-on-location/
To help spread the word, three On Location Ambassadors
are sharing their personal stories about managing food
allergies for the first time during National Asthma and Allergy
Awareness Month. Each of the Ambassadors lives with, or cares for
someone with, food allergies. Captured on camera, "Project Runway"
judge and Creative Director of Marie Claire
Nina Garcia, Chef and cooking competition judge Amanda Freitag and "Girl Meets World" actor
Auggie Maturo and his parents,
discuss why it is important to be prepared should anaphylaxis
occur.
"As a working mom in the high-paced fashion industry, I feel
like my daily to-do list is a mile long, but without a doubt, the
most important item on that list is ensuring my son avoids his
allergic triggers and always has access to two EpiPen
Jr® (epinephrine injection) Auto-Injectors in several
locations including at home, at school and on vacation," said
Garcia, whose 8-year-old son was diagnosed with food allergies to
peanuts and tree nuts as a young child and has experienced
anaphylaxis. "Though I do everything I can to help my son, I've
seen firsthand that life happens, so we've got to be prepared."
Garcia, Freitag and the Maturos are asking people to visit
EpiPenOnLocation.com to watch their videos and share them with
friends and family using #OnLocationTips and #promo. With different
life experiences they each have learned the importance of
incorporating their anaphylaxis action plan into their daily lives.
Families managing known severe allergies are encouraged to follow
their own anaphylaxis action plan, which should include 1) avoiding
allergic triggers, 2) recognizing the signs and symptoms of
anaphylaxis, 3) having access to two epinephrine auto-injectors,
such as EpiPen® Auto-Injectors, at all times and 4)
seeking immediate emergency medical care should anaphylaxis
occur.
Participants who share the EpiPen® On Location
videos from May 7 – July 9, 2015 will be entered into a
Mylan-sponsored sweepstakes for a chance to win one of three,
three-night/four-day Walt Disney World Resort vacations for four to
be taken during the 2015 Epcot International Food & Wine
Festival, which runs between Sept. 25
– Nov. 16, 2015. Up to three shares
per week will be considered toward a chance to win. The grand prize
packages include a resort stay, theme park tickets, a vacation
travel kit prepared by Nina Garcia
and more. Plus, if winners travel between
Oct. 2 and 4, 2015, they will also have an opportunity to
attend culinary demonstrations and educational seminars featuring
Chef Freitag and Auggie Maturo and
his family. The sweepstakes will run through July 9, 2015. For the official sweepstakes rules,
visit www.epipen.com/EOLTC.
Mylan and Walt Disney Parks &
Resorts are committed to supporting guests with severe allergies.
The companies formed an alliance in late 2014 to increase awareness
of anaphylaxis and enhance access to epinephrine.
"Anaphylaxis is unpredictable, and one reaction does not predict
the next. Those at increased risk should avoid their allergic
triggers, have access to two epinephrine auto-injectors everywhere
they go and know how to use them immediately, if needed," said
Maeve O'Connor, MD, FACAAI, FAAAAI,
FACP, Allergy, Asthma and Immunology Relief of Charlotte, N.C. "When it comes to anaphylaxis,
the time to think about being prepared is before it happens so that
you are immediately ready to respond; this is what the
EpiPen® On Location program is all
about."
Nina Garcia, Amanda Freitag, Auggie
Maturo and his parents and Dr. Maeve
O'Connor are paid spokespeople of Mylan.
About Anaphylaxis
Anaphylaxis is a life-threatening allergic reaction that has
many possible triggers, occurs quickly, without warning, and must
be treated immediately with epinephrine. Symptoms may include
hives, itching, swelling or redness of the skin, tightness in the
throat, nausea, dizziness, breathing problems, a decrease in blood
pressure and/or fainting. Anaphylaxis can be caused by triggers,
such as food, stinging and biting insects, medicines, latex or even
exercise. While symptoms of an allergic reaction vary from person
to person, reactions can quickly progress to become
life-threatening.
An epinephrine auto-injector, such as
EpiPen® (epinephrine injection) Auto-Injector,
should be given at the first sign of anaphylaxis, followed by
seeking immediate emergency medical care. Delays in epinephrine
administration have been associated with negative health
consequences, even possibly death.
EpiPen® Auto-Injector is approved for the emergency
treatment of life-threatening allergic reactions (anaphylaxis) and
for people who are at increased risk for anaphylaxis.
Antihistamines, such as Benadryl®, are not approved for
these uses and should not be substituted for epinephrine. Despite
these facts, the use of antihistamines is the most common reason
reported for not using epinephrine and may place a patient at
significantly increased risk for progression toward a
life-threatening allergic reaction. In addition, the use of certain
antihistamines can increase the effects of epinephrine, so talk to
your doctor before using antihistamines with EpiPen®
Auto-Injector.
Indications
EpiPen® (epinephrine injection) 0.3 mg and
EpiPen Jr® (epinephrine injection) 0.15 mg
Auto-Injectors are for the emergency treatment of life-threatening
allergic reactions (anaphylaxis) caused by allergens, exercise, or
unknown triggers; and for people who are at increased risk for
these reactions. EpiPen® and EpiPen
Jr® are intended for immediate administration as
emergency supportive therapy only. Seek immediate emergency medical
help right away.
Important Safety Information
EpiPen® and EpiPen
Jr® Auto-Injectors contain a single dose of
epinephrine, which you (or your caregiver or others who may be in a
position to administer EpiPen® or EpiPen
Jr®) inject into the middle of your outer thigh (upper
leg) (through clothing, if necessary). Get emergency medical help
right away. You may need further medical attention. Only a
health care professional should give additional doses of
epinephrine if you need more than two injections for a single
anaphylactic episode. DO NOT INJECT INTO YOUR VEINS, BUTTOCKS,
FINGERS, TOES, HANDS OR FEET. In case of accidental injection,
please seek immediate medical treatment. Epinephrine should be used
with caution if you have heart disease or are taking certain
medicines that can cause heart-related (cardiac) symptoms.
Tell your doctor if you have certain medical conditions such as
asthma, depression, thyroid disease, Parkinson's disease, diabetes,
high blood pressure or heart disease, have any other medical
conditions, are pregnant or plan to become pregnant, or are
breastfeeding or plan to breastfeed. Be sure to also tell your
doctor all the medicines you take, especially medicines for
asthma. If you have certain medical conditions, or take
certain medicines, your condition may get worse or you may have
longer lasting side effects when you
use EpiPen® or EpiPen
Jr®.
The most common side effects may include increase in heart rate,
stronger or irregular heartbeat, sweating, nausea or vomiting,
difficulty breathing, paleness, dizziness, weakness, shakiness,
headache, apprehension, nervousness or anxiety. These side effects
may go away if you rest. Tell your health care
professional if you have any side effect that bothers you or that
does not go away.
Please see the full Prescribing Information and Patient
Information.
You are encouraged to report negative side effects of
prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
For additional information, please contact us at
800-395-3376.
About EpiPen® (epinephrine injection)
Auto-Injector
EpiPen® (epinephrine injection) and EpiPen
Jr® (epinephrine injection) Auto-Injectors are used
for the emergency treatment of life-threatening allergic reactions.
Each EpiPen 2-Pak® and EpiPen Jr
2-Pak® contains two single auto-injectors,
instructions for use and an EpiPen® Trainer, with
no drug or needle, to help patients become familiar with the
administration technique. EpiPen® Auto-Injector
should be administered immediately at the first sign of an
anaphylactic reaction. EpiPen® Auto-Injector is not
a substitute for emergency medical treatment. Patients should seek
emergency medical attention immediately following administration.
EpiPen® Auto-Injector has been the No. 1 prescribed
epinephrine auto-injector in the U.S. for more than 25 years and
has a simple, three-step administration process. For more
information about EpiPen® Auto-Injector, please
visit www.EpiPen.com.
About Mylan
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of around 1,400 generic pharmaceuticals and several brand
medications. In addition, we offer a wide range of antiretroviral
therapies, upon which approximately 40% of HIV/AIDS patients in
developing countries depend. We also operate one of the largest
active pharmaceutical ingredient manufacturers and currently market
products in about 145 countries and territories. Our workforce of
approximately 30,000 people is dedicated to creating better health
for a better world, one person at a time. Learn more at
mylan.com.
EpiPen®, EpiPen Jr®, EpiPen
2-Pak® and EpiPen Jr 2-Pak® are
registered trademarks of Mylan Inc. licensed exclusively to its
wholly-owned subsidiary, Mylan Specialty L.P. ON LOCATION™ is a
trademark of Mylan Inc. Walt Disney
World® Resort and Epcot®
International Food & Wine Festival are registered trademarks of
Disney. All other trademarks are the property of their respective
owners.
© 2015 Mylan Specialty L.P. All rights reserved.
EPI-2015-0343
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/fashion-icon-chef-and-actor-join-together-to-share-personal-stories-of-managing-life-threatening-allergies-in-new-campaign-300079374.html
SOURCE Mylan